Loading clinical trials...

A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT03744182

A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

This study is a phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of HM15211 in obese subjects with NAFLD

Lead sponsor: Hanmi Pharmaceutical Company Limited•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NCT05424003 · NAFLD

RECRUITINGNA

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

NCT05884723 · Liver Steatoses, Liver Metastasis Colon Cancer, and more

RECRUITING

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

NCT07265544 · Liver Neoplasm, HBV Infection, and more

RECRUITING

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more

RECRUITINGNA

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD

NCT04681573 · NAFLD

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 27, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment66

Start dateNov 2018

Last updatedJan 27, 2025

Condition

NAFLD

Locations shown

ProSciento Inc.

Chula Vista, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions